4,0
16. Juni 2012
Mitarbeiter (anonym)
Ehemaliger Mitarbeiter, mehr als 5 Jahre
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Strong innovative company. Nice product portfolio. They will continue to thrive in the US. Healthcare is their biggest and strongest arm in the US.
Kontras
They cut costs to stay profitable but at the expense of possibly overworking their field engineers. The products they sell tend to be higher price but higher quality. It will be a harder sell since the Healthcare Reform.